Iovance Biotherapeutics Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Corporate Update

Go back to Iovance Biotherapeutics Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Corporate Update
(NASDAQ: IOVA) Delayed: 8.43 -0.27 (3.1%)
Previous Close $8.70    52 Week High
Open $8.65    52 Week Low
Day High $8.73    P/E N/A 
Day Low $8.32    EPS
Volume 11,931,167